Kyung Ah Han

5PUBLICATIONS
34CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomicsExperimental economicsExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 26, 2026
Efficacy and Safety of Fixed-Dose Combinations of Sitagliptin and Empagliflozin as Add-On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double-Blind, Multi-Centre, Placebo-Controlled, Phase III Trial.

Soo Lim, Tae Nyun Kim, Ji Oh Mok

|Dec 19, 2025
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trial.

Seung-Hwan Lee, Kyung Ah Han, Eun-Gyoung Hong

|Jul 26, 2024
Long-term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52-week extension of a Phase 3 randomized controlled trial.

Soo Heon Kwak, Kyung Ah Han, Eun Sook Kim

|Jul 09, 2024
Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study.

Kyung Ah Han, You-Cheol Hwang, Shin Je Moon

|Nov 27, 2019
Body Fat Is Related to Sedentary Behavior and Light Physical Activity but Not to Moderate-Vigorous Physical Activity in Type 2 Diabetes Mellitus.

Keun Hee An, Kyung Ah Han, Tae Seo Sohn

Pageof 1

Frequent Collaborators

3 joint publications

Jong Chul Won

2 joint publications

Eun Seok Kang

2 joint publications

Ho Chan Cho

2 joint publications

You-Cheol Hwang